Evaluation of Seasonal Inactivated Influenza Vaccines Prophylactic Efficacy

Evaluation of Seasonal Inactivated Influenza Vaccines Prophylactic Efficacy

Relevance. Seasonal flu vaccination is still the most effective way to protect against flu viruses and help to reduce the burden of flu illnesses. Another possible benefit is the impact of yearly vaccines on severity of breakthrough infection. In this regard, the issue of choosing safe vaccine with...

Full description

Bibliographic Details
Main Authors:	K. V. Zhdanov, K. Kasyanenko, O. V. Mal'cev, N. I. L'vov, D. A. Lioznov, I. I. Lapikov, K. S. Ivanov
Format:	Article
Language:	Russian
Published:	Numikom LLC 2022-11-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	quadrivalent vaccine flu vaccine adjuvanted flu vaccine influenza prophylaxis
Online Access:	https://www.epidemvac.ru/jour/article/view/1679

Similar Items

Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
by: D. A. Lioznov
Published: (2018-09-01)

A 12-month follow-up of an influenza vaccination campaign based on voluntary adherence: report on upper-respiratory symptoms among volunteers and non-volunteers
by: Páris Ali Ramadan, et al.

Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”
by: Sanjay Hadigal, et al.
Published: (2023-08-01)

Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
by: Sanjay Hadigal, et al.
Published: (2022-11-01)

Do We Still Need to Vaccinate Patients Against Flu After the Flu Infection?
by: Dilan Yağmur KUTLAY, et al.
Published: (2024-08-01)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
by: Rodrigo Luiz Carregaro, et al.
Published: (2023-08-01)

Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults
by: Ahmed Tawfik, et al.
Published: (2023-12-01)

Epidemiology of influenza over a ten-year period in Belgium: overview of the historical and current evidence
by: A. Prezzi, et al.
Published: (2023-11-01)

Nurses’ Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature
by: Natacha Pinatel, et al.
Published: (2022-06-01)

Evaluation of knowledge and barriers of influenza vaccine uptake among university students in Saudi Arabia; a cross-sectional analysis
by: Tauqeer Hussain Mallhi, et al.
Published: (2022-09-01)

Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022–2023 season
by: Stefania Roncaglia, et al.
Published: (2024-05-01)

Influenza Vaccine Uptake in Italy—The 2022–2023 Seasonal Influenza Vaccination Campaign in Italy: An Update from the OBVIOUS Project
by: Angelo Capodici, et al.
Published: (2024-03-01)

The Knowledge and Perceptions of Florida Pharmacists in Administering Inactivated Influenza Vaccines to Pregnant Women
by: Oluyemisi Falope, et al.
Published: (2021-04-01)

Impact of Influenza Vaccination on Mortality in the Oldest Old: A Propensity Score-Matched Cohort Study
by: Pauline Walzer, et al.
Published: (2020-07-01)

NEW GENERATION DOMESTIC VACCINE FOR PROPHYLAXIS OF FLU
by: O. V. Shamsheva
Published: (2015-09-01)

Clinical and immunological efficacy of immunoprophylaxis of influenza in children with allergic diseases
by: E. G. Bokuchava, et al.
Published: (2016-12-01)

Preventive vaccination against influenza today
by: O. S. Konshina, et al.
Published: (2016-12-01)

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population
by: Anna Fochesato, et al.
Published: (2022-08-01)

The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities
by: Pritish Mondal, et al.
Published: (2022-02-01)

[Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy]
by: Vincenzo Baldo, et al.
Published: (2022-11-01)

A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community
by: Magdalena Grochowska, et al.
Published: (2021-05-01)

Influenza Vaccination Assessment according to a Value-Based Health Care Approach
by: Giovanna Elisa Calabrò, et al.
Published: (2022-10-01)

An Assessment of Pharmacy School Curricula in Florida and Inactivated Influenza Vaccine (IIV) Administration to Pregnant Women
by: Oluyemisi Falope, et al.
Published: (2021-03-01)

Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive)
by: Viktor V. Romanenko, et al.
Published: (2024-07-01)

Attitudes and Perception of Healthcare Workers Concerning Influenza Vaccination during the 2019/2020 Season: A Survey of Sicilian University Hospitals
by: Claudio Costantino, et al.
Published: (2020-11-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
by: D. V. Bukhanova, et al.
Published: (2018-07-01)

Influenza vaccination in the elderly
by: Jan Smetana, et al.
Published: (2018-03-01)

Effect of Vaccination against Pneumococcal Infection and Influenza on the Clinical Course of Bronchial Asthma
by: N. P. Andreeva, et al.
Published: (2019-09-01)

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

Detection of Twitter Users\' Attitudes about Flu Vaccine based on the Content and Sentiment Analysis of the Sent Tweets
by: Zahra Ghanbari, et al.
Published: (2019-03-01)

Immunisation of young children against influenza — evidence review
by: V. A. Bulgakova, et al.
Published: (2022-10-01)

Adherence Population to Vaccination of Influenza: Survey Results
by: T. A. Bayanova, et al.
Published: (2021-03-01)

Socioeconomic costs of influenza complications in hospitalized children
by: August Wrotek, et al.
Published: (2020-09-01)

Influenza A viruses: Current perspectives on swine flu virus
by: Martin E Ohanu, et al.
Published: (2019-01-01)

Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return
by: Litjen J. Tan, et al.
Published: (2022-11-01)

Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy
by: Eulhae Ga, et al.
Published: (2024-03-01)

Targeting the hallmarks of aging to improve influenza vaccine responses in older adults
by: Andreia N. Cadar, et al.
Published: (2023-05-01)

Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01)

INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY
by: Giuseppe La Torre
Published: (2016-09-01)

Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea
by: Youngji Song, et al.
Published: (2024-12-01)